Skip to main content
MTNB logo

MTNB

Matinas BioPharma Holdings, Inc.

$0.34

2.60%

Trade Ideas Performance

Latest Closed Trade Idea

$0.34

2.60%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

6

Social

3

About

Events of Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma's stock price has declined significantly by approximately -72.71% over the past six months. The company received a notice from NYSE American indicating non-compliance with continued listing standards on April 3, 2026. On March 31, 2026, Matinas BioPharma announced staff reductions and is actively seeking a partner for MAT2203. Jerome D. Jabbour was appointed interim Chief Financial Officer on January 23, 2026. The company amended its CEO contract to include extended change-in-control bonus protections on December 12, 2025. Matinas BioPharma announced a planned CFO departure on November 21, 2025.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Matinas BioPharma Holdings, Inc. (MTNB) Live Stock Price, Chart & Financial News | Edge Hound